These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 18636086)
1. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. Friedman CS; O'Donnell MA; Legarda-Addison D; Ng A; Cárdenas WB; Yount JS; Moran TM; Basler CF; Komuro A; Horvath CM; Xavier R; Ting AT EMBO Rep; 2008 Sep; 9(9):930-6. PubMed ID: 18636086 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response. Xu C; He X; Zheng Z; Zhang Z; Wei C; Guan K; Hou L; Zhang B; Zhu L; Cao Y; Zhang Y; Cao Y; Ma S; Wang P; Zhang P; Xu Q; Ling Y; Yang X; Zhong H J Virol; 2014 Oct; 88(19):11356-68. PubMed ID: 25056901 [TBL] [Abstract][Full Text] [Related]
3. TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1. Lee Y; Song B; Park C; Kwon KS PLoS One; 2013; 8(5):e63255. PubMed ID: 23675467 [TBL] [Abstract][Full Text] [Related]
4. DDX3 directly regulates TRAF3 ubiquitination and acts as a scaffold to co-ordinate assembly of signalling complexes downstream from MAVS. Gu L; Fullam A; McCormack N; Höhn Y; Schröder M Biochem J; 2017 Feb; 474(4):571-587. PubMed ID: 27980081 [TBL] [Abstract][Full Text] [Related]
5. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. Zhang M; Wu X; Lee AJ; Jin W; Chang M; Wright A; Imaizumi T; Sun SC J Biol Chem; 2008 Jul; 283(27):18621-6. PubMed ID: 18467330 [TBL] [Abstract][Full Text] [Related]
6. Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production. Nistal-Villán E; Gack MU; Martínez-Delgado G; Maharaj NP; Inn KS; Yang H; Wang R; Aggarwal AK; Jung JU; García-Sastre A J Biol Chem; 2010 Jun; 285(26):20252-61. PubMed ID: 20406818 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways. Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550 [TBL] [Abstract][Full Text] [Related]
8. DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling. Miyashita M; Oshiumi H; Matsumoto M; Seya T Mol Cell Biol; 2011 Sep; 31(18):3802-19. PubMed ID: 21791617 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein. Jiang J; Tang H Protein Cell; 2010 Dec; 1(12):1106-17. PubMed ID: 21213104 [TBL] [Abstract][Full Text] [Related]
11. DEAD/H BOX 3 (DDX3) helicase binds the RIG-I adaptor IPS-1 to up-regulate IFN-beta-inducing potential. Oshiumi H; Sakai K; Matsumoto M; Seya T Eur J Immunol; 2010 Apr; 40(4):940-8. PubMed ID: 20127681 [TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol-3-kinase and Akt are required for RIG-I-mediated anti-viral signalling through cross-talk with IPS-1. Yeon SH; Song MJ; Kang HR; Lee JY Immunology; 2015 Feb; 144(2):312-20. PubMed ID: 25158146 [TBL] [Abstract][Full Text] [Related]
13. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations. Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176 [TBL] [Abstract][Full Text] [Related]
14. RACK1 attenuates RLR antiviral signaling by targeting VISA-TRAF complexes. Xie T; Chen T; Li C; Wang W; Cao L; Rao H; Yang Q; Shu HB; Xu LG Biochem Biophys Res Commun; 2019 Jan; 508(3):667-674. PubMed ID: 30527812 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. Mibayashi M; Martínez-Sobrido L; Loo YM; Cárdenas WB; Gale M; García-Sastre A J Virol; 2007 Jan; 81(2):514-24. PubMed ID: 17079289 [TBL] [Abstract][Full Text] [Related]
16. A Src-family-tyrosine kinase, Lyn, is required for efficient IFN-β expression in pattern recognition receptor, RIG-I, signal pathway by interacting with IPS-1. Lim YJ; Koo JE; Hong EH; Park ZY; Lim KM; Bae ON; Lee JY Cytokine; 2015 Mar; 72(1):63-70. PubMed ID: 25585356 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. Yu S; Chen J; Wu M; Chen H; Kato N; Yuan Z J Gen Virol; 2010 Aug; 91(Pt 8):2080-2090. PubMed ID: 20375222 [TBL] [Abstract][Full Text] [Related]
18. Ataxia telangiectasia mutated kinase mediates NF-κB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection. Fang L; Choudhary S; Tian B; Boldogh I; Yang C; Ivanciuc T; Ma Y; Garofalo RP; Brasier AR J Virol; 2015 Mar; 89(5):2628-42. PubMed ID: 25520509 [TBL] [Abstract][Full Text] [Related]
19. TRAF5 is a downstream target of MAVS in antiviral innate immune signaling. Tang ED; Wang CY PLoS One; 2010 Feb; 5(2):e9172. PubMed ID: 20161788 [TBL] [Abstract][Full Text] [Related]
20. Human kinome analysis reveals novel kinases contributing to virus infection and retinoic-acid inducible gene I-induced type I and type III IFN gene expression. Nousiainen L; Sillanpää M; Jiang M; Thompson J; Taipale J; Julkunen I Innate Immun; 2013 Oct; 19(5):516-30. PubMed ID: 23405030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]